TABLE 1.
Clinicopathological data of patients with G2 RNETs
| Clinicopathological factors | Total N = 144 | |
|---|---|---|
| n | IQR or % | |
| Sex, n (%) | ||
| Male | 88 | 61.1% |
| Female | 56 | 38.9% |
| Age, y (IQR) | 51.0 | (40.0–64.0) |
| Tumor size, cm (IQR) | 1.5 | (0.7–2.2) |
| Distance from the anus, cm (IQR) | 5.0 | (3.5–8.0) |
| T stage, n (%) | ||
| T1 | 89 | 61.8% |
| T2 | 24 | 16.7% |
| T3 | 22 | 15.3% |
| T4 | 9 | 6.3% |
| Distant metastasis, n (%) | ||
| Negative | 132 | 91.7% |
| Positive | 12 | 8.3% |
| Resection type, n (%) | ||
| Endoscopic resection | 27 | 18.8% |
| Transanal excision | 55 | 38.2% |
| RR | 50 | 34.7% |
| Only biopsy | 3 | 2.1% |
| Palliative surgery | 9 | 6.3% |
| Microvascular invasion, n (%) | ||
| Negative | 126 | 87.5% |
| Positive | 18 | 12.5% |
| Perineural invasion, n (%) | ||
| Negative | 131 | 91.0% |
| Positive | 13 | 9.0% |
IQR = interquartile range; RNET = rectal neuroendocrine tumor; RR, radical resection.